NAMS updates position statement on menopausal hormone therapy

Omicron subvariants and the changing landscape of COVID-19
20 July 2022
Majority of stroke patients with depression do not receive mental health treatment
20 July 2022

NAMS updates position statement on menopausal hormone therapy

Hormone therapy remains the most effective treatment for vasomotor symptoms (VMS) and genitourinary syndrome of menopause, according to a position statement issued by the North American Menopause Society (NAMS) and published online July 7 in Menopause.

Comments are closed.